Related Experiment Videos
Amiodarone: what have we learned from clinical trials?
G V Naccarelli1, D L Wolbrette, J T Dell'Orfano
1Section of Cardiology, Penn State University College of Medicine, Milton S. Hershey Medical Center, PennState Geisinger Health System, Hershey 17033, USA.
Clinical Cardiology
|February 17, 2000
Summary
Amiodarone, an antiarrhythmic drug, effectively reduces arrhythmias but does not improve overall survival in post-myocardial infarction patients. Implantable cardioverter-defibrillators (ICDs) show superior survival benefits over amiodarone for certain ventricular tachyarrhythmias.
Area of Science:
- Cardiology
- Clinical Trials
- Pharmacology
Background:
- Amiodarone is a widely used antiarrhythmic medication for supraventricular and ventricular tachyarrhythmias.
- Clinical trial evidence is crucial for understanding amiodarone's efficacy and safety in diverse cardiac conditions.
Purpose of the Study:
- To review clinical trials evaluating amiodarone in various patient populations.
- To compare amiodarone's effectiveness against other treatments, including implantable cardioverter-defibrillators (ICDs).
Main Methods:
- Review of key clinical trials such as EMIAT, CAMIAT, CHF/STAT, GESICA, MADIT, CASCADE, AVID, CIDS, and CASH.
- Analysis of amiodarone's impact on mortality, arrhythmic events, and survival in specific cardiac conditions.
Main Results:
- Amiodarone reduced arrhythmic mortality post-myocardial infarction but not overall mortality (EMIAT, CAMIAT).
- Survival outcomes with amiodarone varied in congestive heart failure (CHF) patients (neutral in CHF/STAT, improved in GESICA).
- Implantable cardioverter-defibrillator (ICD) therapy demonstrated superior overall survival compared to amiodarone in several trials (AVID, CIDS, CASH).
Conclusions:
- Amiodarone effectively manages arrhythmias but offers limited survival benefits in certain contexts, particularly post-myocardial infarction.
- ICD therapy is superior to amiodarone for improving overall survival in patients with sustained ventricular tachycardia/ventricular fibrillation (VT/VF).
- The clinical application of amiodarone requires careful consideration of trial data and patient-specific factors.